Prevalence of hepatitis C virus infection and HCV genotypes among hemophiliacs in the State of Bahia, Northeastern Brazil: Analysis of serological and virological parameters

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 38, Issue 6, 2005, Pages 496-502

  Silva, Luciano Kalabric ^a   Souza Da Silva, Maria Betânia ^a   Lopes, Gisele Barreto ^a   Rodart, Itatiana Ferreira ^a   Costa, Fernando Quadros ^a   Santana, Nelma P ^b   Paraná, Raymundo ^c   Santana, Aurelino ^d   Galvão Dos Reis, Mitermayer ^a,c,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Secretaria da Saude do Estado da Bahia   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d FDC   (Brazil)

Author keywords

Bahia; Genotype; Hemophilia; Hepatitis C virus; Prevalence

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9 INHIBITORY ANTIBODY; HEPATITIS C ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD TRANSFUSION; BRAZIL; CHILD; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENOTYPE; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREVALENCE; SEROLOGY; SEROPREVALENCE; VIREMIA; VIROLOGY; VIRUS TRANSMISSION;

HEPATITIS C VIRUS;

EID: 31644441271     PISSN: 00378682     EISSN: 00378682     Source Type: Journal    
DOI: 10.1590/S0037-86822005000600010     Document Type: Article

References (49)

1. Allain JP, Dailey SH, Laurian Y, Vallari DS, Rafowicz A, Desai SM, Devare SG. Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs. Journal of Clinical Investigation 88: 1672-1679, 1991.
2. Alric L, Fort M, Izopet J, Vinel JP, Bureau C, Sandre K, Charlet JP, Beraud M, Abbal M, Duffaut M. Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 56: 154-158, 2000.
3. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. New England Journal of Medicine 327: 1899-1905, 1992.
4. Barbosa AP, Martins RM, Teles SA, Silva SA, Oliveira JM, Yoshida CF. Prevalence of hepatitis C Virus infection among hemophiliacs in Central Brazil. Memórias do Instituto Oswaldo Cruz 97: 643-644, 2002.
5. Bassit L, Ribeiro-Dos-Santos G, Da Silva LC, Takei K, Villaca P, David-Neto E, Chamone D, Saez-Alquezar A. Genotype distributions of hepatitis C virus in Sao Paulo, Brazil: rare subtype found [letter]. Hepatology 29: 994-995, 1999.
6. Carmo RA, Oliveira GC, Guimaraes MD, Oliveira MS, Lima AA, Buzek SC, Correa-Oliveira R, Rocha MO. Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study. Brazilian Journal of Medical and Biological Research 35: 589-598, 2002.
7. Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. Journal of General Virology 73: 1131-1141, 1992.
8. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362, 1989.
9. Colombo M, Mannucci PM, Carnelli V, Savidge GF, Gazengel C, Schimpf K. Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate. Lancet 2: 1-4, 1985.
10. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, Krusius T, Lin C, Medgyesi GA, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. Journal of General Virology 76: 1197-1204, 1995.
11. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 2: 294-297, 1989.
12. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. New England Journal of Medicine 292: 767-770, 1975.
13. Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. British Medical Journal 287: 1754-1757, 1983.
14. Horowitz MS, Rooks C, Horowitz B, Hilgartner MW. Virus safety of solvent/detergent-treated antihaemophilic factor concentrate. Lancet 2: 186-189, 1988.
15. Kernoff PB, Lee CA, Karayiannis P, Thomas HC. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. British Journal of Haematology 60: 469-479, 1985.
16. Kohara M, Tanaka T, Tsukiyama-Kohara K, Tanaka S, Mizokami M, Lau JY, Hattori N. Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics. Journal of Infectious Diseases 172: 934-938, 1995.
17. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364, 1989.
18. Lanotte P, Dubois F, Le Pogam S, Guerois C, Fimbel B, Bacq Y, Gruel Y, Goudeau A, Barin F. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. Journal of Infectious Diseases 178: 556-559, 1998.
19. Laskus T, Wang LF, Rakela J, Vargas H, Pinna AD, Tsamandas AC, Demetris AJ, Fung J. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology 220: 171-176, 1996.
20. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 25: 1250-1254, 1997.
21. Maisonneuve P, Laurian Y, Guerois C, Verroust F, Ferrer Le Coeur F, Courouce AM, Noel L. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs. Nouvelle Revue Francaise D'Hematologie 33: 263-266, 1991.
22. Makris M, Garson JA, Ring CJ, Tuke PW, Tedder RS, Preston FE. Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. Blood 81: 1898-1902, 1993.
23. Makris M, Preston FE, Triger DR, Underwood JC, Choo QL, Kuo G, Houghton M. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 335: 1117-1119, 1990.
24. Martins RM, Barbosa AP, Oliveira JM, Vanderborght B, Yoshida CF. Genotype analysis of hepatitis C virus in Brazilian hemophiliacs and blood donors. Vox Sanguinis 78: 255, 2000.
25. Martins RMB, Vanderborght BO, Yoshida CF. Hepatitis C virus genotypes among blood donors from different regions of Brazil. Mem. Inst. Oswaldo Cruz 93: 299-300, 1998.
26. Mauser-Bunschoten EP, Bresters D, van Drimmelen AA, Roosendaal G, Cuypers HT, Reesink HW, van der Poel CL, van den Berg HM, Lelie PN. Hepatitis C infection and viremia in Dutch hemophilia patients. Journal of Medical Virology 45: 241-246, 1995.
27. Mazur W, Mazurek U, Jurzak M, Wilczok T, Bulanowski Z, Gonciarz Z. Positive and negative strands of HCV-RNA in sera and peripheral blood mononuclear cells of chronically hemodialyzed patients. Medical Science Monitoring 7: 108-115, 2001.
28. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. Journal of Clinical Microbiology 32: 884-892, 1994.
29. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 20: 1131-1136, 1994.
30. Pasi KJ, Evans DJ, Skidmore SJ, Hill FGH. Prevention of hepatitis C virus infection in haemophiliacs. Lancet 1: 1474, 1990.
31. Perret BA, Senn M, Affentranger P, Poorbeik M, Burckhardt JJ, Morell A. [Seroprevalence of hepatitis C virus in hemophiliacs in Switzerland]. Schweizerische Medizinische Wochenschrift 123: 79-81, 1993.
32. Pistello M, Ceccherini-Nelli L, Cecconi N, Bendinelli M, Panicucci F. Hepatitis C virus seroprevalence in Italian haemophiliacs injected with virus-inactivated concentrates: five year follow-up and correlation with antibodies to other viruses. Journal of Medical Virology 33: 43-46, 1991.
33. Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, Kaneko S, Unoura M, Kobayashi K. Severity of liver disease with different hepatitis C viral clones [letter]. Lancet 338: 509, 1991.
34. Rocha VG, Carmo RA, Murao M, Mourão JG, Ribeiro CMF, Martins MVCL, Viana MB. Predictive factors for the presence of hepatitis C virus antibodies in hemophiliacs: multivariate analysis. In: Resumo do Congresso da Sociedade Brasileira de Medicina Tropical, Salvador p. 368, 1994.
35. Rockstroh JK, Spengler U, Sudhop T, Ewig S, Theisen A, Hammerstein U, Bierhoff E, Fischer HP, Oldenburg J, Brackmann HH, Sauerbruch T. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. American Journal of Gastroenterology 91: 2563-2568, 1996.
36. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press 3 New York, 1989.
37. Sarrazin C. Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance. Journal Clinical of Virology 25(supl 3): S23-29, 2002.
38. Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology 32: 818-823, 2000.
39. Schmidt WN, Klinzman D, LaBrecque DR, Macfarlane DE, Stapleton JT. Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells. Journal of Medical Virolology 47: 153-160, 1995.
40. Schmidt WN, Wu P, Cederna J, Mitros FA, LaBrecque DR, Stapleton JT. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. Journal of Infectious Diseases 176: 27-33, 1997.
41. Schimpf K, Mannucci PM, Kreutz W, Brackmann HH, Auerswald G, Ciavarella N, Mosseler J, DeRosa V, Kraus B, Brueckmann C, et al. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. New England Journal of Medicine 316: 918-922, 1987.
42. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, Brugnetti B, Civardi E, Salvaneschi L, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21: 285-290, 1995.
43. Simmonds P, Balfe P, Ludlam CA, Bishop JO, Brown AJ. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. Journal of Virology 64: 5840-5850, 1990.
44. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology 74: 2391-2399, 1993.
45. Sugitani M, Inchauspe G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 339: 1018-1019, 1992.
46. Toyoda H, Fukuda Y, Hayakawa T, Kumada T, Nakano S, Takamatsu J, Saito H. Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: evidence for transient or occult superinfection with HCV of different genotypes. American Journal of Gastroenterology 94: 2230-2236, 1999.
47. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, Parmley R, Sexauer C, Gomperts E, Buchanan G, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 81: 412-418, 1993.
48. Velasco M, Hurtado C, Brahm J. Anti-hepatitis C viral antibodies in different pathological entities in Chile. Revista Medica de Chile 118: 895-896, 1990.
49. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group [see comments]. Annals of Internal Medicine 125: 634-639, 1996.